-
In this article and the succeeding two parts in this series, three distinctive applications of ultrasound in the ED will be discussed. The ability to perform a proficient and diagnostically effective ultrasound examination requires a judicious understanding of the underlying principles.
-
-
Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients with Isolated Systolic Hypertension and LVH; Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes; HRT, Lipid, and Glucose Metabolism in Diabetic and Nondiabetic Postmenopausal Women; Effects of Long-Term Treatment With ACE Inhibitors in the Presence or Absence of Aspirin; Long-Term Risks Associated with Atrial Fibrillation: 20-Year Follow-up of the Renfrew/Paisley Study; Olfactory Impairment in Older Adults
-
-
CHICAGO, Illinois Important new developments in the diagnosis of cardiovascular disease were described during the annual scientific sessions of the American Heart Association, along with advances in monitoring technologies and minimally invasive therapy.
-
CHICAGO, Illinois Implanting lifesaving heart pumps in people with severe congestive heart failure costs about the same as heart, liver and other transplants, according to a study reported during the American Heart Associations annual scientific sessions here in November.
-
Quantitative software programs developed for use with cardiovascular magnetic resonance imaging, such as the QVA-CMS package from Medis (Leiden, Netherlands), have been proposed by Dr. Michel Romanens of the Radiology Diagnostic Centers in Switzerland as offering good performance in the assessment of heart function and of shunt problems.
-
Collaborations, distribution agreements, partnerships, and product development collaborations.
-
Pacing the heart, a common and accepted medical practice, may damage patients hearts, at least in some circumstances, according to a preliminary study that was terminated early because too many patients died.
-
A trilogy of cardiovascular products from three separate companies received good news on the regulatory front the week before Christmas.
